14 April 2023
Pharmacopoea Helvetica 12 and Addendum 11.1 of the European Pharmacopoeia in force
The 12th edition of the Swiss Pharmacopoeia has been published since October 2022. The Institute Council has put it into force on 1 April 2023. In addition, the Institute Council has also put Addendum 11.1 of the European Pharmacopoeia into force on 1 April 2023.
More News
-
-
Swissmedic: New strategic Approach to minimizing Animal Testing in the Development of Medicinal Products
-
Swissmedic: The new Pharmacopoea Helvetica 13
-
European Medicines Agency: New oral GLP-1 Medicine for Weight Management and Type 2 Diabetes
-
FOPH: Capital Income of Health Insurers for Premium Reduction – current voluntary System deemed sufficient
-
Swissmedic: Haemovigilance Annual Report 2025
-
Decision C-6534/2024 of 13 October 2026
-
Swissmedic: GMP Compliance by foreign Manufacturers - Simplifications for Industry and Clarification of unresolved Issues
-
European Medicines Agency: Clinical Trial Applications Advice Pilot becomes permanent
-
Swissmedic: Revision of the Guidance document Authorisation Biosimilar